Skip to content
10-K

Annual Report

Avant Diagnostics, Inc

0001213900-18-011800

← back to feed
Filed
Aug 28, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Aug 7, 2018 336.96M sh
Operating Cash Flow FY 2016 · Sep 30, 2015 −$201.61K
Current Liabilities FY 2016 · Sep 30, 2015 $621.32K
Total Liabilities FY 2016 · Sep 30, 2015 $621.32K
Current Assets FY 2016 · Sep 30, 2015 $43.68K
Total Assets FY 2016 · Sep 30, 2015 $1.84M
Sga Expense restated FY 2016 · Sep 30, 2015 $566.42K
Net Income FY 2016 · Sep 30, 2015 −$3.34M
Operating Income FY 2016 · Sep 30, 2015 −$1.34M
Cash And Equivalents FY 2016 · Sep 30, 2014 $6K
Stockholders Equity FY 2016 · Sep 30, 2014 $3.13M